XML 67 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Collaborative Research, Development, and License Agreements - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 05, 2022
Feb. 22, 2022
Mar. 31, 2025
May 31, 2011
Mar. 31, 2009
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2016
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Total Revenues           $ 144,000 $ 109,000  
Licensing Agreements [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Amortization expense of licenses           $ 3,000 5,000  
Weighted average remaining amortization period for all licenses           2 years    
Annual amortization expense of licenses year 1     $ 2,000     $ 2,000    
Annual amortization expense of licenses year 2     2,000     2,000    
Annual amortization expense of licenses year 3     2,000     2,000    
BICO Group AB [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Nonrefundable upfront fee paid   $ 1,500,000            
BICO Group AB [Member] | Sales Based Royalties [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Total Revenues           119,000 109,000  
University of Missouri [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Royalty fees percentage minimum         1.00%      
Royalty fees percentage maximum         3.00%      
Upfront payment $ 50,000,000              
Clemson University [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Minimum annual royalty paid           40,000 $ 40,000  
Upfront payment           $ 0    
Minimum annual royalty payment due               $ 40,000
Clemson University [Member] | Sublicense Agreements [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Percentage of royalty revenue from sublicensee           40.00%    
Clemson University [Member] | Licensing Agreements [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Royalty fees percentage minimum       1.50%        
Royalty fees percentage maximum       3.00%        
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Royalty fees percentage minimum           1.00%    
Royalty fees percentage maximum           1.125%    
Amount paid at the closing of the sale     $ 100,000          
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member] | 45 days of Dosing of First Patient in a Phase III Clinical Trial [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Milestone payments           $ 500,000    
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member] | 45 days of FDA Approval of First Licensed Product [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Milestone payments           1,000,000    
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member] | 45 Days of First Commercial Sale of Licensed Product in Territory [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Milestone payments           $ 1,500,000